1. Home
  2. HELE vs TRDA Comparison

HELE vs TRDA Comparison

Compare HELE & TRDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Helen of Troy Limited

HELE

Helen of Troy Limited

HOLD

Current Price

$14.99

Market Cap

390.4M

ML Signal

HOLD

TRDA

Entrada Therapeutics Inc.

HOLD

Current Price

$11.91

Market Cap

481.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HELE
TRDA
Founded
1968
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Home Furnishings
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
390.4M
481.6M
IPO Year
1996
2021

Fundamental Metrics

Financial Performance
Metric
HELE
TRDA
Price
$14.99
$11.91
Analyst Decision
Hold
Strong Buy
Analyst Count
2
2
Target Price
$22.00
$20.00
AVG Volume (30 Days)
459.8K
188.4K
Earning Date
04-23-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,478,845,000.00
$25,421,000.00
Revenue This Year
N/A
$39.97
Revenue Next Year
$0.72
$53.29
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$15.03
$4.93
52 Week High
$54.25
$13.99

Technical Indicators

Market Signals
Indicator
HELE
TRDA
Relative Strength Index (RSI) 32.26 48.02
Support Level N/A $9.78
Resistance Level $19.26 $12.56
Average True Range (ATR) 0.71 0.88
MACD -0.12 -0.11
Stochastic Oscillator 13.24 27.21

Price Performance

Historical Comparison
HELE
TRDA

About HELE Helen of Troy Limited

Helen Of Troy Ltd is a consumer products company offering creative products and solutions for its customers through a diversified portfolio of brands. It has two operating segments: Home and Outdoor segment provides a broad range of consumer products for home activities such as food preparation, cooking, cleaning, and organization; as well as products for outdoor and on-the-go activities such as hydration, food storage, backpacks, and travel gear, and The Beauty and Wellness segment provides beauty and wellness products including mass and prestige market beauty appliances, prestige market liquid-based hair and personal care products, and wellness devices including thermometers, water and air filtration systems, humidifiers, and fans.

About TRDA Entrada Therapeutics Inc.

Entrada Therapeutics Inc is a clinical-stage biopharmaceutical company. It aims to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient intracellular delivery into a variety of organs and tissues, resulting in an improved therapeutic index and protein-based programs for the potential treatment of neuromuscular and ocular diseases, among others. Its oligonucleotide programs are in development for the potential treatment of people living with Duchenne, which are exon 44, 45, 50, and 51 skipping amenable. It has partnered to develop a clinical-stage program, VX-670, for myotonic dystrophy type 1.

Share on Social Networks: